Gamithromycin (150 mg/mL), an antimicrobial for SQ administration in beef and non-lactating dairy cattle for the treatment of Mycoplasma bovis and is labeled as a first-pull treatment for all major pathogens of bovine respiratory disease (BRD) associated with Mannheimia haemolytica, Pasturella multocida and Histophilus somni. Also indicated for control of respiratory disease in beef and non-lactating dairy cattle at high risk of developing BRD associated with Mannheimia haemolytica and Pasturella multocida. Do not use in female dairy cattle 20 months and older or in calves to be processed for veal.